Company Profile: N-of-One: realizing personalized medicine

Author： Carter Jennifer Levin   Elkin Sheryl   Barton Joan  

Publisher： Future Medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.8, Iss.3, 2011-05, pp. : 311-315

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Company Profile: HistoRx: tissue-based diagnostic solutions for personalized medicine

By Dolled-Filhart Marisa   Romeo Elisa   Adams Kathleen   Davis Wendy   Gustavson Mark  

Personalized Medicine, Vol. 9, Iss. 2, 2012-03 ,pp. : 185-190

Future Medicine

Access to resources Recommend Favorite

Company Profile: Strategic Medicine, Inc. and Strategic Medicine, BV

By Liebman Michael N  

Personalized Medicine, Vol. 10, Iss. 7, 2013-09 ,pp. : 633-637

Future Medicine

Access to resources Recommend Favorite

Regulatory Focus: Bringing home the genome: the US FDA’s role in realizing personalized medicine

By Hamburg Margaret  

Personalized Medicine, Vol. 7, Iss. 3, 2010-05 ,pp. : 239-242

Future Medicine

Access to resources Recommend Favorite

Institutional Profile: The Center for Biomarker Research and Personalized Medicine at Virginia Commonwealth University: advancing psychiatric drug treatment

By McClay Joseph L  

Personalized Medicine, Vol. 9, Iss. 5, 2012-07 ,pp. : 479-483

Future Medicine

Access to resources Recommend Favorite

From blockbuster medicine to personalized medicine

By Jøørgensen Jan Trøøst  

Personalized Medicine, Vol. 5, Iss. 1, 2008-01 ,pp. : 55-63

Future Medicine

Access to resources Recommend Favorite